PL425725A1 - Produkt leczniczy zawierający wodny roztwór metyzoprynolu o ulepszonej trwałości - Google Patents

Produkt leczniczy zawierający wodny roztwór metyzoprynolu o ulepszonej trwałości

Info

Publication number
PL425725A1
PL425725A1 PL42572518A PL42572518A PL425725A1 PL 425725 A1 PL425725 A1 PL 425725A1 PL 42572518 A PL42572518 A PL 42572518A PL 42572518 A PL42572518 A PL 42572518A PL 425725 A1 PL425725 A1 PL 425725A1
Authority
PL
Poland
Prior art keywords
methisoprinol
water solution
containing water
product containing
improved stability
Prior art date
Application number
PL42572518A
Other languages
English (en)
Inventor
Krzysztof Durko
Jacek Maleszyk
Sylwia Tobólska
Original Assignee
Przed Wielobranzowe Vet Agro Spolka Z Ograniczona Odpowiedzialnoscia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Przed Wielobranzowe Vet Agro Spolka Z Ograniczona Odpowiedzialnoscia filed Critical Przed Wielobranzowe Vet Agro Spolka Z Ograniczona Odpowiedzialnoscia
Priority to PL42572518A priority Critical patent/PL425725A1/pl
Priority to PCT/PL2018/000053 priority patent/WO2019226058A1/en
Publication of PL425725A1 publication Critical patent/PL425725A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01B—MACHINES OR ENGINES, IN GENERAL OR OF POSITIVE-DISPLACEMENT TYPE, e.g. STEAM ENGINES
    • F01B9/00—Reciprocating-piston machines or engines characterised by connections between pistons and main shafts, not specific to groups F01B1/00 - F01B7/00
    • F01B9/02—Reciprocating-piston machines or engines characterised by connections between pistons and main shafts, not specific to groups F01B1/00 - F01B7/00 with crankshaft
    • F01B9/026—Rigid connections between piston and rod; Oscillating pistons
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/32—Engines characterised by connections between pistons and main shafts and not specific to preceding main groups
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/025—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle two
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B2730/00—Internal-combustion engines with pistons rotating or oscillating with relation to the housing
    • F02B2730/02—Internal-combustion engines with pistons rotating or oscillating with relation to the housing with piston rotating around its axis and having a reciprocating movement in a cylinder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Combustion & Propulsion (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest preparat, który zawiera 1-dimetyloaminopropan-2ol 4-acetamidobenzoesan w ilości od ponad 2 do 14% wagowych w stosunku do ilości 1-dimetyloaminopropano-2olu 4-acetamidobenzoesanu zawartego w rozpuszczonym metyzoprynolu. Zgłoszenie obejmuje także zastosowanie wymienionej soli na nadawania trwałości wodnym roztworom metyzoprynolu w niskich temperaturach.
PL42572518A 2018-05-24 2018-05-24 Produkt leczniczy zawierający wodny roztwór metyzoprynolu o ulepszonej trwałości PL425725A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL42572518A PL425725A1 (pl) 2018-05-24 2018-05-24 Produkt leczniczy zawierający wodny roztwór metyzoprynolu o ulepszonej trwałości
PCT/PL2018/000053 WO2019226058A1 (en) 2018-05-24 2018-05-28 Medicinal product containing improved stability water solution of methisoprinol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL42572518A PL425725A1 (pl) 2018-05-24 2018-05-24 Produkt leczniczy zawierający wodny roztwór metyzoprynolu o ulepszonej trwałości

Publications (1)

Publication Number Publication Date
PL425725A1 true PL425725A1 (pl) 2019-12-02

Family

ID=62817050

Family Applications (1)

Application Number Title Priority Date Filing Date
PL42572518A PL425725A1 (pl) 2018-05-24 2018-05-24 Produkt leczniczy zawierający wodny roztwór metyzoprynolu o ulepszonej trwałości

Country Status (2)

Country Link
PL (1) PL425725A1 (pl)
WO (1) WO2019226058A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4259151A4 (en) * 2020-12-10 2025-01-29 Reena Patel Methisoprinol compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270832B (it) * 1993-09-20 1997-05-13 Luciano Brugola Composizione farmaceutica antivirale contenente la 2-ammino 4,6 dicloropirimidina e metisoprinolo.
PL194749B1 (pl) * 2001-08-30 2007-06-29 Przed Wielobranzowe Vet Agro S Preparat żelazowy
CN1965893A (zh) * 2006-11-13 2007-05-23 浙江大学 一种治疗过敏性鼻炎用的液体制剂
PL223158B1 (pl) * 2008-08-12 2016-10-31 Przedsiębiorstwo Wielobranżowe Vet Agro Spółka Z Ograniczoną Zastosowanie metyzoprynolu
CN106619691A (zh) * 2016-12-02 2017-05-10 郑州莉迪亚医药科技有限公司 异丙肌苷在制备治疗老年痴呆症药物中的用途

Also Published As

Publication number Publication date
WO2019226058A1 (en) 2019-11-28

Similar Documents

Publication Publication Date Title
BR112015007546A2 (pt) composições de ácido percarboxílico estáveis e usos das mesmas
UA110653C2 (uk) Фунгіцидна композиція і спосіб боротьби з хворобами рослин
MX375261B (es) Compuestos aromaticos sustituidos para el tratamiento de la fibrosis pulmonar, la fibrosis hepatica, la fibrosis de la piel y la fibrosis cardiaca.
MX2015011054A (es) Composicion de glifosato para mezclas de tanque con dicamba con volatilidad mejorada.
MX391156B (es) Forma polimorfica de sepiapterina.
AR098829A1 (es) Composiciones acuosas diluidas de saflufenacilo
PH12015502802A1 (en) Formulation comprising a hypolipidemic agent
EA201690079A1 (ru) Композиция, содержащая глутаминовую-n,n-диуксусную кислоту (glda), воду и фермент
NZ614434A (en) High-strength, low viscosity herbicidal concentrate of clopyralid dimethylamine
BR112012017994B8 (pt) composição líquida, uso de uma composição líquida, e, métodos para preparar uma composição líquida e para tratamento de um distúrbio
EA201892563A1 (ru) Композиция для местного применения
RU2017106269A (ru) Вспомогательные средства для водоподготовки, способствующие низкой летучести
MX348979B (es) Agente de control de enfermedades de las plantas.
EA201591642A1 (ru) Брусок мыла, обладающий повышенной антибактериальной активностью
UA116403C2 (uk) Співкристал діамідного та неонікотиноїдного інсектицидно активних інгредієнтів та спосіб його одержання
PL425725A1 (pl) Produkt leczniczy zawierający wodny roztwór metyzoprynolu o ulepszonej trwałości
CR20150650A (es) Derivados de etinilo como antagonistas receptores de glutamato metabotrópico
EA201592140A1 (ru) Композиция для ухода за волосами
BR112015020076A2 (pt) composição agroquímica suspensa aquosa
MX2015012211A (es) Liquidos ionicos y usos de los mismos.
RU2014127543A (ru) Порошковая композиция для дезинфекции ванн для копытных животных
EA202091002A1 (ru) Стабилизация солевых растворов и смесей солевых растворов, содержащих йодид
EA201792582A1 (ru) Композиция для придания формы волосам
AR119659A1 (es) Composición adhesiva y método para su preparación
BR112015023750A2 (pt) composição agricolamente ativa concentrada; método de preparação da composição pronta para uso; composição pronta para uso; e método para o tratamento de uma planta